Brizy

Levosalbutamol (Oral) ·Eskayef Pharmaceuticals Ltd.·Tablet

0 views 0 reviews

Packages & prices

Pack	Price	Details
Unit Price	৳ 100.00	Unit Price: ৳ 2.00 (5 x 10: ৳ 100.00)

Administration

Tablet-

Adults and adolescents above 12 years: 1-2 mg three times daily.
Children (6 -11 years): 1 mg three times daily.

Syrup-

Adults : 5-10 ml three times daily.
Childrn (6-11 years): 5 ml three times daily.

Effects

Hypocalcaemia, palpitation, fine tremors of the skeletal muscle and muscle cramps may occur. The other likely side effects are nausea, vomiting, burning substernal or epigastric pain and diarrhoea.

Indications

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

Pharmacology

Levosalbutamol is a single isomer beta 2-agonist that differs from racemic salbutamol by elimination of (S)-salbutamol. Levosalbutamol is an effective bronchodilator whose primary mechanism of action is unimpeded by (S)-salbutamol. Thus, when compared with racemic salbutamol, clinically comparable bronchodilation can be achieved with doses that substantially lessen beta-mediated side effects.

Precautions

Particular caution is advised in acute severe asthma as this effect may be potentiated by hypoxia and by concomitant treatment with xanthine derivatives, steroids and diuretics. Serum potassium levels should be monitored in such situations.